NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001265

Registered date:24/07/2008

Pilot study of chemopreventive effect of pioglitazone for colorectal cancer using aberrant crypt foci as a biomarker

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedSubjects with aberrant crypt foci (ACF)
Date of first enrollment2004/04/01
Target sample size40
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Oral administration of pioglitazone in 15mg daily. No administration of newly drug.

Outcome(s)

Primary OutcomeObservation of ACF using magnifying endoscopy
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaa. Liver cirrhosis or chronic hepatic, chronic renal failure b. Women who are pregnant or with a possibility of pregnancy c. Alcohol dependence or drug dependence d. Drug allergy e. Heart failure f. Those who have started to use different medication for diabetes mellitus from pioglitazone-alone (including insulin) in study period g. The patient that it is already taken pioglitazone h. History of cancer i. Family history of colorectal cancer j. The patient currently taking NSAIDs k. Inadequate to entry to this study

Related Information

Contact

public contact
Name Hirokazu Takahashi
Address 3-9 Fuku-ura, Kanazawa-ku, Yokohama, Japan Japan
Telephone
E-mail
Affiliation Yokohama City University Graduate School of Medicine Gastroenterology Division
scientific contact
Name Atsushi Nakajima
Address 3-9 Fuku-ura, Kanazawa-ku, Yokohama, Japan Japan
Telephone
E-mail
Affiliation Yokohama City University Graduate School of Medicine Gastroenterology Division